Stock listing
NASDAQ:VERU Veru Inc. Stock
Home listing (NASDAQ) of Veru Inc.
Follow Veru Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:VERU
$2.19 USD -0.04 (-1.8%)
Close on Oct 30, 2026
- Day range
- $2.16 – $2.26 USDOct 30, 2026
- Volume
- 78,878 sharesOct 30, 2026
- Market cap
- $37.34M USDAt the close on Oct 30, 2026 · price × 17.05M shares outstanding
- 52-week range
- $2.05 – $7.33 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $549,310 USDMedian day 137,200 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VERU · Home | $2.19 USD | -0.04 (-1.8%) | 78,878 | $2.25 | $2.26 | $2.16 | $2.23 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:VERU · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.19 | -0.04 | -1.8% | $2.25 | $2.26 | $2.16 | 78,878 | |
| $2.23 | -0.04 | -1.8% | $2.27 | $2.33 | $2.22 | 56,935 | |
| $2.27 | -0.01 | -0.4% | $2.27 | $2.30 | $2.24 | 73,162 | |
| $2.28 | +0.07 | +3.2% | $2.22 | $2.34 | $2.22 | 157,711 | |
| $2.21 | -0.03 | -1.3% | $2.25 | $2.26 | $2.18 | 86,578 | |
| $2.24 | -0.05 | -2.2% | $2.29 | $2.32 | $2.22 | 122,600 | |
| $2.29 | -0.01 | -0.4% | $2.30 | $2.30 | $2.24 | 85,800 | |
| $2.30 | -0.08 | -3.4% | $2.37 | $2.41 | $2.28 | 99,800 | |
| $2.38 | +0.07 | +3.0% | $2.31 | $2.40 | $2.31 | 89,700 | |
| $2.31 | +0.01 | +0.4% | $2.30 | $2.35 | $2.27 | 88,100 | |
| $2.30 | -0.14 | -5.7% | $2.41 | $2.48 | $2.27 | 305,400 | |
| $2.44 | +0.31 | +14.6% | $2.14 | $2.48 | $2.12 | 505,300 | |
| $2.13 | -0.06 | -2.7% | $2.26 | $2.29 | $2.11 | 275,200 | |
| $2.19 | -0.22 | -9.1% | $2.41 | $2.42 | $2.18 | 169,200 | |
| $2.41 | -0.05 | -2.0% | $2.44 | $2.45 | $2.40 | 85,500 | |
| $2.46 | +0.04 | +1.7% | $2.42 | $2.49 | $2.42 | 128,900 | |
| $2.42 | -0.04 | -1.6% | $2.44 | $2.52 | $2.39 | 147,600 | |
| $2.46 | -0.01 | -0.4% | $2.42 | $2.54 | $2.41 | 202,400 | |
| $2.47 | -0.08 | -3.1% | $2.54 | $2.75 | $2.44 | 1,517,500 | |
| $2.55 | +0.04 | +1.6% | $2.51 | $2.62 | $2.50 | 88,600 | |
| $2.51 | -0.03 | -1.2% | $2.56 | $2.56 | $2.50 | 104,900 | |
| $2.54 | -0.12 | -4.5% | $2.65 | $2.65 | $2.53 | 70,700 | |
| $2.66 | +0.10 | +3.9% | $2.58 | $2.70 | $2.51 | 183,000 | |
| $2.56 | +0.03 | +1.2% | $2.53 | $2.58 | $2.50 | 33,100 | |
| $2.53 | -0.01 | -0.4% | $2.52 | $2.57 | $2.51 | 101,300 | |
| $2.54 | +0.03 | +1.2% | $2.55 | $2.57 | $2.50 | 115,800 | |
| $2.51 | +0.05 | +2.0% | $2.42 | $2.52 | $2.42 | 87,400 | |
| $2.46 | -0.04 | -1.6% | $2.49 | $2.51 | $2.43 | 94,000 | |
| $2.50 | +0.06 | +2.5% | $2.46 | $2.52 | $2.42 | 121,400 | |
| $2.44 | +0.03 | +1.2% | $2.44 | $2.49 | $2.43 | 158,200 | |
| $2.41 | +0.02 | +0.8% | $2.39 | $2.44 | $2.36 | 102,900 | |
| $2.39 | +0.07 | +3.0% | $2.35 | $2.40 | $2.35 | 93,900 | |
| $2.32 | -0.02 | -0.9% | $2.34 | $2.37 | $2.31 | 130,300 | |
| $2.34 | 0.00 | 0.0% | $2.36 | $2.36 | $2.29 | 125,300 | |
| $2.34 | -0.10 | -4.1% | $2.41 | $2.44 | $2.34 | 207,500 | |
| $2.44 | -0.06 | -2.4% | $2.52 | $2.53 | $2.43 | 239,300 | |
| $2.50 | +0.02 | +0.8% | $2.52 | $2.53 | $2.46 | 181,400 | |
| $2.48 | -0.10 | -3.9% | $2.59 | $2.59 | $2.48 | 264,800 | |
| $2.58 | -0.06 | -2.3% | $2.81 | $2.85 | $2.55 | 1,340,500 | |
| $2.64 | -0.01 | -0.4% | $2.65 | $2.73 | $2.63 | 143,500 | |
| $2.65 | -0.10 | -3.6% | $2.75 | $2.77 | $2.65 | 75,400 | |
| $2.75 | +0.06 | +2.2% | $2.70 | $2.76 | $2.65 | 202,600 | |
| $2.69 | -0.11 | -3.9% | $2.80 | $2.82 | $2.69 | 203,200 | |
| $2.80 | +0.17 | +6.5% | $2.63 | $2.83 | $2.59 | 250,000 | |
| $2.63 | -0.11 | -4.0% | $2.71 | $2.73 | $2.61 | 92,700 | |
| $2.74 | -0.06 | -2.1% | $2.82 | $2.84 | $2.71 | 122,500 | |
| $2.80 | +0.09 | +3.3% | $2.73 | $2.82 | $2.70 | 169,400 | |
| $2.71 | +0.12 | +4.6% | $2.60 | $2.79 | $2.60 | 227,020 | |
| $2.59 | -0.05 | -1.9% | $2.64 | $2.64 | $2.50 | 102,569 | |
| $2.64 | +0.06 | +2.3% | $2.56 | $2.68 | $2.56 | 177,500 | |
| $2.58 | -0.06 | -2.3% | $2.65 | $2.68 | $2.52 | 135,400 | |
| $2.64 | +0.05 | +1.9% | $2.60 | $2.66 | $2.59 | 139,000 | |
| $2.59 | -0.04 | -1.5% | $2.61 | $2.63 | $2.54 | 119,100 | |
| $2.63 | -0.10 | -3.7% | $2.70 | $2.71 | $2.61 | 127,200 | |
| $2.73 | +0.03 | +1.1% | $2.70 | $2.76 | $2.64 | 159,000 | |
| $2.70 | -0.04 | -1.5% | $2.76 | $2.76 | $2.65 | 182,100 | |
| $2.74 | -0.05 | -1.8% | $2.78 | $2.80 | $2.71 | 199,600 | |
| $2.79 | +0.02 | +0.7% | $2.75 | $2.83 | $2.69 | 456,300 | |
| $2.77 | +0.44 | +18.9% | $2.45 | $2.89 | $2.33 | 1,603,100 | |
| $2.33 | +0.02 | +0.9% | $2.36 | $2.39 | $2.31 | 258,600 | |
| $2.31 | -0.02 | -0.9% | $2.35 | $2.42 | $2.28 | 234,700 | |
| $2.33 | -0.04 | -1.7% | $2.39 | $2.39 | $2.30 | 89,800 | |
| $2.37 | +0.11 | +4.9% | $2.30 | $2.40 | $2.27 | 256,300 | |
| $2.26 | +0.02 | +0.9% | $2.32 | $2.32 | $2.21 | 236,500 | |
| $2.24 | +0.02 | +0.9% | $2.26 | $2.27 | $2.17 | 153,700 | |
| $2.22 | +0.01 | +0.5% | $2.21 | $2.27 | $2.19 | 132,100 |
- Ticker
- NASDAQ:VERU
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 8, 2026
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
Latest earnings call · Aug 10, 2026
Veru (NASDAQ:VERU) Q3 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
2026 Cantor Global Healthcare Conference
Conference · 59 slides
Calls
Replays
Veru (NASDAQ:VERU) Q3 2026 Earnings Call
Mon, Aug 10, 2026 · 8:00 AM ET
Watch TranscriptVeru (NASDAQ:VERU) Q2 2026 Earnings Call
Wed, May 13, 2026 · 8:00 AM ET
Watch TranscriptVeru (NASDAQ:VERU) Q1 2026 Earnings Call
Wed, Feb 04, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
Sep 8, 2026
Closed $2.58 (-2.3%) on Sep 8, 2026
Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference
Sep 2, 2026
Closed $2.75 (+2.2%) on Sep 2, 2026
Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
Aug 10, 2026
Closed $2.77 (+18.9%) on Aug 10, 2026
Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
Aug 4, 2026
Closed $2.37 (+4.9%) on Aug 4, 2026
Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th
Aug 3, 2026
Closed $2.26 (+0.9%) on Aug 3, 2026
Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference
Jul 30, 2026
Closed $2.22 (+0.5%) on Jul 30, 2026
Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Jul 27, 2026
Closed $2.28 (+1.3%) on Jul 27, 2026
Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
Jul 7, 2026
Closed $2.88 (+1.8%) on Jul 7, 2026
Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
May 13, 2026
Closed $2.26 (-0.4%) on May 13, 2026
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
May 6, 2026
Closed $2.22 (+0.5%) on May 6, 2026
Decks
2026 Cantor Global Healthcare Conference
Conference · 59 slides · September 2026
Q2 2026 Earnings Presentation
Earnings · 8 slides · May 13, 2026
4th Edition of World Obesity and Weight Management Congress 2024
Conference · 34 slides · Oct 24, 2024
2024 Cantor Global Healthcare Conference
Conference · 45 slides · September 2024
Veru Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 148 in all · newest Sep 8, 2026 · oldest 2019
- Calls
- 19 calls with a replay · 19 with a transcript · latest Aug 10, 2026
- Decks
- 38 decks · latest September 2026
Where Veru Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VERU · Home listing · This page | NASDAQ | United States | USD |
| BOATS:VERU | BOATS | United States | USD |
| gettex:FMW0 | gettex | Germany | EUR |
| Frankfurt:FMW0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A41ES4 | Lang & Schwarz | Germany | EUR |
| LS Exchange:A41ES4 | LS Exchange | Germany | EUR |
| Munich:FMW0 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Veru Inc.